New diabetes monitor put to the test
NCT ID NCT05806554
Summary
This study tested how well a new continuous glucose monitor (CGM) called the True Vie I3 tracks blood sugar levels in people with diabetes. 159 adults with type 1 or type 2 diabetes who use insulin wore the device for up to 15 days. Researchers compared the monitor's readings to blood draws taken during clinic visits to check its accuracy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta Diabetes Associates
Atlanta, Georgia, 30318, United States
-
Diablo Clinical Research
Walnut Creek, California, 94598, United States
-
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Ulm, D-89081, Germany
-
PSHI Praxis GmbH
Mainz, 55128, Germany
-
Rainier Clinical Research Center
Renton, Washington, 98057, United States
-
Woodland Research Northwest
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.